Nuventra Pharma Sciences is now part of Allucent. Nuventra is the pharmaceutical industry’s go-to resource for clinical pharmacology, pharmacokinetic, and pharmacometric consulting services. Nuventra gives pharmaceutical companies and CROs rare access to a hands-on team of industry-leading consultants experienced in complex studies and analyses. We embrace the notion that simplicity and clarity lead to good decisions by taking complex pharmacokinetic and pharmacometric principals and making them understandable and usable for common sense drug development. Nuventra’s flexible business structure enables us to integrate with our clients and help them maximize the potential of clinical pharmacology studies and pharmacokinetic analyses to pave the way toward marketing approval. For more information visit www.nuventra.com
Looking for a particular Nuventra Pharma Sciences employee's phone or email?
The Nuventra Pharma Sciences annual revenue was $15.6 million in 2026.
Michael Lamson is the Vice President, Pharmacokinetics and Clinical Pharmacology of Nuventra Pharma Sciences.
9 people are employed at Nuventra Pharma Sciences.
The NAICS codes for Nuventra Pharma Sciences are [32, 3254, 32541, 325].
The SIC codes for Nuventra Pharma Sciences are [28, 283].